Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum
Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
CCSVI.nl is onderdeel van de
Franz Schelling Website
meer informatie
  
Friday, August 17, 2012 11:37 PM | Ken Torbert Volg link

Thank you for joining the Hubbard Foundation Newsletter, we're excited to be able to share news, updates, and important discussions with you through this monthly newsletter. -Team Hubbard







Healthy Living


Nutrition, Exercise, Relaxation


Most of us have been told that cholesterol is bad.  Here is some information that might change your mind.  Read here for more information.


 


 






Join Team Hubbard!



August Edition


What's News



  • See below, Dr. Hubbard's update on the FDA

  • BMC Neurology discussion of Grey Matter damage in MS click here 

  •  Angioneurines might be important in CNS restoration click here

  •  Dr. Sclafani's paper on the importance of intravascular ultrasound (IVUS) in the evaluation of CCSVI click here for the abstract.


 


 


 

Ask Dr. Hubbard







David Hubbard MD
David Hubbard MD, is a neurologist and fMRI researcher in San Diego, CA. He is the chairman of the Hubbard Foundation and treasurer of the ISNVD, the International Society for NeuroVascular Disease. He has been researching the vascular connection in MS since his son's diagnosis in 2009.

The Hubbard Foundation and Dr. Hubbard thank you for your questions. Please continue to send in your short questions that are relavent to other readers Newsletter@HubbardFoundation.org


 Dr. Hubbard's Update on the FDA


On Wednesday 7/25/12 an FDA Fidld Office inspector met with one of our sites and told them verbally to discontinue enrolling subjects in the Hubbard Foundation Registry. The inspector said that they were aware the Hubbard Foundation had requested ID exemption and believed that new guidelines will be prepared by September.  The Hubbard Foundation has still not received a direct response from the FDA.  We are still confident there is no legitimate reason for the FDA to deny our request.


About the Hubbard Foundation


When David Hubbard MD, world renowned neurologist, and his wife Arlene Hubbard MS OTR/L, learned their son had Multiple Sclerosis (MS), they decided to use fMRI to investigate Multiple Sclerosis in order to find prevention, treatment and ultimately a cure for this disease.


The mission of the Hubbard Foundation is to research the vascular component of neurological disorders, like Chronic Cerebrospinal Venous Insufficiency (CCSVI) in Multiple Sclerosis, using functional MRI (fMRI) as well MRV, flow-quantification, perfusion and other measures. There are three components to the Foundation:


Research


Treatment


Education



As of June 2012 over 400 people were enrolled at our center in San Diego, and almost 300 through the national registry. Thousands more receive information through our online educational resources and annual conference.


Let's go with the flow!


www.HubbardFoundation.org